Bravo, maybe not $100M, but certainly way more tha
Post# of 36537
(Total Views: 282)
Posted On: 09/28/2020 1:09:45 PM
Bravo, maybe not $100M, but certainly way more than $2.5M. We will need a phase I/II trial. Then at least 30K participants in a Phase 3 trial, like the other companies are doing. What funding did BARDA give them? Hundreds of millions to over a billion dollars to each company to run trials and secure vaccine doses.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼